EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:749530 - hyaluronidase (human recombinant)
| ChEBI ID | CHEBI:749530 |
| ChEBI Name | hyaluronidase (human recombinant) |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Biological Roles: | anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. hypoglycemic agent A drug which lowers the blood glucose level. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antipsoriatic A drug used to treat psoriasis. anti-inflammatory agent Any compound that has anti-inflammatory effects. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role analgesic (CHEBI:35480) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role anti-HIV agent (CHEBI:64946) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role anti-inflammatory agent (CHEBI:67079) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role antineoplastic agent (CHEBI:35610) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role antipsoriatic (CHEBI:50748) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role bone density conservation agent (CHEBI:50646) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role dermatologic drug (CHEBI:50177) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role hypoglycemic agent (CHEBI:35526) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role immunosuppressive agent (CHEBI:35705) |
| hyaluronidase (human recombinant) (CHEBI:749530) is a organic molecular entity (CHEBI:50860) |
| INNs | Source |
|---|---|
| vorhialuronidasa alfa | WHO MedNet |
| vorhyaluronidase alfa | WHO MedNet |
| Synonyms | Source |
|---|---|
| Chemophase | ChEMBL |
| Enhanze | ChEMBL |
| Human hyaluronidase | ChEMBL |
| Hyaluronidase fihj | ChEMBL |
| Hyaluronidase-fihj | ChEMBL |
| Hyaluronidase (human) | ChEMBL |
| Brand Names | Source |
|---|---|
| Cumulase | ChEMBL |
| Hyaluronidase (human recombinant) component of lispro-ph20 rhuph20 | ChEMBL |
| Hylenex | ChEMBL |
| Hylenex recombinant | ChEMBL |